Chong Kun Dang Rises 11.5% Amid Bio-Similar (Biosimilar Drug) Theme Uptrend

On the 21st, the biosimilar (generic biopharmaceutical) theme showed strength by rising 3.06% compared to the previous day, while Chong Kun Dang, a related stock attracting attention, surged 11.5% compared to the previous day. Chong Kun Dang is known as a top pharmaceutical company in the industry focused on therapeutics.

[Graph] Major stock price changes in the biosimilar (generic biopharmaceutical) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Chong Kun Dang ranked 2nd out of 17 stocks in the quant financial ranking by exceeding the theme’s average scores in growth, stability, and profitability. This can be interpreted as Chong Kun Dang having a relatively high investment attractiveness compared to other stocks in the theme from a financial perspective.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.